Average Co-Inventor Count = 13.52
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (21 from 2,405 patents)
2. Schering Corporation (2 from 1,829 patents)
3. Albany Molecular Research, Inc. (1 from 97 patents)
23 patents:
1. 12466831 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
2. 12459927 - Plasma kallikrein inhibitors
3. 12428397 - Factor XI activation inhibitors
4. 12414952 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
5. 12304899 - Factor XI activation inhibitors
6. 11046714 - 2,2-difluorodioxolo Areceptor antagonists
7. 10822338 - Substituted aminoquinazoline compounds as Aantagonist
8. 10472347 - Aminopyrazine compounds with A2A antagonist properties
9. 10143681 - Factor XIa inhibitors
10. 10138212 - [object Object]
11. 10081617 - Factor XIa inhibitors
12. 10011585 - Factor XIa inhibitors
13. 10011615 - Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
14. 9868727 - Factor XIa inhibitors
15. 9783530 - Factor Xla inhibitors